Entegrion, a Research Triangle=based life sciences company developing advanced blood products, has raised $4.2 million of a $5 million debt and securities offering from 59 investors, according to a regulatory filing.
Entegrion is a North Carolina-based life sciences firm that develops and supplies products such as viscoelastic coagulation monitor and FFP systems for the healthcare sector.